332 related articles for article (PubMed ID: 15569840)
1. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.
Tokmakova MP; Skali H; Kenchaiah S; Braunwald E; Rouleau JL; Packer M; Chertow GM; Moyé LA; Pfeffer MA; Solomon SD
Circulation; 2004 Dec; 110(24):3667-73. PubMed ID: 15569840
[TBL] [Abstract][Full Text] [Related]
2. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
3. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA;
Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009
[TBL] [Abstract][Full Text] [Related]
4. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
Anavekar NS; McMurray JJ; Velazquez EJ; Solomon SD; Kober L; Rouleau JL; White HD; Nordlander R; Maggioni A; Dickstein K; Zelenkofske S; Leimberger JD; Califf RM; Pfeffer MA
N Engl J Med; 2004 Sep; 351(13):1285-95. PubMed ID: 15385655
[TBL] [Abstract][Full Text] [Related]
5. Effect of pravastatin on cardiovascular events in people with chronic kidney disease.
Tonelli M; Isles C; Curhan GC; Tonkin A; Pfeffer MA; Shepherd J; Sacks FM; Furberg C; Cobbe SM; Simes J; Craven T; West M
Circulation; 2004 Sep; 110(12):1557-63. PubMed ID: 15364796
[TBL] [Abstract][Full Text] [Related]
6. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.
Murcia AM; Hennekens CH; Lamas GA; Jiménez-Navarro M; Rouleau JL; Flaker GC; Goldman S; Skali H; Braunwald E; Pfeffer MA
Arch Intern Med; 2004 Nov; 164(20):2273-9. PubMed ID: 15534166
[TBL] [Abstract][Full Text] [Related]
7. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.
McCullough PA; Li S; Jurkovitz CT; Stevens L; Collins AJ; Chen SC; Norris KC; McFarlane S; Johnson B; Shlipak MG; Obialo CI; Brown WW; Vassalotti J; Whaley-Connell AT; Brenner RM; Bakris GL;
Am Heart J; 2008 Aug; 156(2):277-83. PubMed ID: 18657657
[TBL] [Abstract][Full Text] [Related]
8. Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus.
Anavekar NS; Solomon SD; McMurray JJ; Maggioni A; Rouleau JL; Califf R; White H; Kober L; Velazquez E; Pfeffer MA
Am J Cardiol; 2008 Apr; 101(7):925-9. PubMed ID: 18359309
[TBL] [Abstract][Full Text] [Related]
9. Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial.
Jardine MJ; Ninomiya T; Perkovic V; Cass A; Turnbull F; Gallagher MP; Zoungas S; Lambers Heerspink HJ; Chalmers J; Zanchetti A
J Am Coll Cardiol; 2010 Sep; 56(12):956-65. PubMed ID: 20828648
[TBL] [Abstract][Full Text] [Related]
10. CKD and risk of hospitalization and death with pneumonia.
James MT; Quan H; Tonelli M; Manns BJ; Faris P; Laupland KB; Hemmelgarn BR;
Am J Kidney Dis; 2009 Jul; 54(1):24-32. PubMed ID: 19447535
[TBL] [Abstract][Full Text] [Related]
11. Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.
Solomon SD; Rice MM; A Jablonski K; Jose P; Domanski M; Sabatine M; Gersh BJ; Rouleau J; Pfeffer MA; Braunwald E;
Circulation; 2006 Jul; 114(1):26-31. PubMed ID: 16801465
[TBL] [Abstract][Full Text] [Related]
12. Declining renal function after myocardial infarction predicts poorer long-term outcome.
Aengus Murphy C; Robb SD; Weir RA; McDonagh TA; Dargie HJ
Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):181-6. PubMed ID: 19829117
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW
Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
[TBL] [Abstract][Full Text] [Related]
15. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction.
Jose P; Skali H; Anavekar N; Tomson C; Krumholz HM; Rouleau JL; Moye L; Pfeffer MA; Solomon SD
J Am Soc Nephrol; 2006 Oct; 17(10):2886-91. PubMed ID: 16928807
[TBL] [Abstract][Full Text] [Related]
16. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.
Meisinger C; Döring A; Löwel H;
Eur Heart J; 2006 May; 27(10):1245-50. PubMed ID: 16611670
[TBL] [Abstract][Full Text] [Related]
17. The Survival and Ventricular Enlargement (SAVE) study: rationale and perspective.
Pfeffer MA
Herz; 1993 Dec; 18 Suppl 1():430-5. PubMed ID: 8125423
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk among adults with chronic kidney disease, with or without prior myocardial infarction.
Wattanakit K; Coresh J; Muntner P; Marsh J; Folsom AR
J Am Coll Cardiol; 2006 Sep; 48(6):1183-9. PubMed ID: 16979003
[TBL] [Abstract][Full Text] [Related]
19. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Aguilar D; Solomon SD; Køber L; Rouleau JL; Skali H; McMurray JJ; Francis GS; Henis M; O'Connor CM; Diaz R; Belenkov YN; Varshavsky S; Leimberger JD; Velazquez EJ; Califf RM; Pfeffer MA
Circulation; 2004 Sep; 110(12):1572-8. PubMed ID: 15364810
[TBL] [Abstract][Full Text] [Related]
20. The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial.
Brugts JJ; Boersma E; Chonchol M; Deckers JW; Bertrand M; Remme WJ; Ferrari R; Fox K; Simoons ML;
J Am Coll Cardiol; 2007 Nov; 50(22):2148-55. PubMed ID: 18036453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]